Optimising polypharmacotherapy in geriatric patients with the medication review software Medinspector
- Conditions
- Polypharmacy in elderly patientsAppropriateness of medicationMedication therapy safety
- Registration Number
- DRKS00027410
- Lead Sponsor
- Viandar GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
age = 65 years
- permanent intake of = 5 active pharmaceutical substances with systemic effects (combinations of active ingredients in phytotherapeutics and homeopathics are counted as a single active substance)
- written informed consent
- completed software-assisted medication review
Exclusion Criteria
- For patients with more than one completed medication review in the recruitment period, only the first analysis will be considered.
- The inclusion of patients per pharmacy is limited to a maximum of 15% of the calculated samplze size (n = 148), which corresponds to 22 patients per pharmacy.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Appropriateness of medication at t0 (before medication examination) and at t2 (final medication (determined by physician)) measured using a modified version of the Medication Appropriateness Index (MAI) (Hanlon, 1992)<br>Modifications: <br>- Scoring weight of item on indication = „1 point (instead of „3)<br>- Omission of item on cost-effectiveness
- Secondary Outcome Measures
Name Time Method